This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

Fixing racial inequities in lupus care

Fixing racial inequities in lupus care
Analysis of the Deidentified Interview Transcripts to Develop the Main Themes. Lupus CAB indicates the University of Michigan Community Advisory Board for Lupus Care and Research. Credit: JAMA Network Open (2023). DOI: 10.1001/jamanetworkopen.2023.40688

Receiving a lupus diagnosis can be a long and frustrating journey. For Black adults, this already difficult process is usually even more drawn out and comes with its own types of challenges. Sadly, racial inequities are a defining feature in the treatment of Black adults with lupus.

On average, the diagnosis comes later (and for many, it's after having their concerns dismissed), and the severity of symptoms and risk of death are also increased.

"Many Black people are discouraged when it comes to their lupus diagnosis because they are not seen as being in enough pain or having enough symptoms," said Rachel Bergmans, M.P.H., Ph.D., a research investigator at the University of Michigan Department of Anesthesiology and lead author of a study describing opportunities to improve care for Black adults with lupus published in JAMA Network Open.

"This treatment can cause people to feel that their experiences are not valid and can deter them from seeking the help they need."

Bergmans and her fellow researchers found that not only were Black people with lupus feeling discouraged about seeing a doctor for fear of their symptoms not being validated, but many were skipping medications due to or high costs.

"Close monitoring of the symptoms not only from lupus but also from the medications people are receiving is crucial to making sure there's success in treatment," said Bergmans.

"Sometimes side effects of different medications are not shared in the context of the person's lupus, so they aren't aware of why they might be having negative side effects or when to talk to a doctor about these side effects.

"Educating on all aspects of the medication and treatment they are receiving and when they should be concerned about side effects is an important part of treating the whole person when it comes to lupus."

Creating more awareness for diagnosis

According to Michelle Kahlenberg, M.D., Ph.D., a professor of rheumatology at the University of Michigan Health and co-author of the study, the first step to combating some of these disparities is by raising awareness about the various ways symptoms of lupus can present to non-rheumatologists, helping improve the diagnosis process, thus creating more referrals.

"It is critical to open a dialogue between patients and their health care team to properly build trust," said Kahlenberg.

"We need to meet patients where they are in terms of understanding their disease, their previous health care experiences, and the difficulties they face in accessing . If we don't understand these aspects of care, we will miss opportunities to bring them to the best health possible."

When it comes to perseverance through this frustrating period, Bergmans suggests using community resources to help find strength.

"Discussing experiences with other lupus warriors who have gone through the same process can help people feel validated in their journey and frustrations," said Bergmans.

"Using a site such as Conquer Lupus to hear the stories of those who have lupus can give validation to the challenges of having ."

More information: Bhaavna Yalavarthi et al, Recommendations for Improving Systemic Lupus Erythematosus Care From Black Adults, JAMA Network Open (2023). DOI: 10.1001/jamanetworkopen.2023.40688

Journal information: JAMA Network Open
Citation: Fixing racial inequities in lupus care (2023, November 21) retrieved 2 May 2024 from https://medicalxpress.com/news/2023-11-racial-inequities-lupus.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Clinical trial generates promising results for obinutuzumab in patients with lupus nephritis

1 shares

Feedback to editors